Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study

BACKGROUND: In breast cancer and prostate cancer patients, bone metastases (BM) present the main cause of morbidity and often cause debilitating pain, impaired functioning and subsequent deterioration of quality of life (QoL). The management of BM is still challenging. Maintenance or improvement in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakob, Andreas, Zahn, Mark-Oliver, Nusch, Arnd, Werner, Thorsten, Schnell, Roland, Frank, Melanie, Hamm, Nicole, Däßler, Klaus-Ulrich, Losem, Christoph, Welslau, Manfred, Hoevel, Petra, Potthoff, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941198/
https://www.ncbi.nlm.nih.gov/pubmed/35340302
http://dx.doi.org/10.1016/j.jbo.2022.100420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941198/
https://www.ncbi.nlm.nih.gov/pubmed/35340302
http://dx.doi.org/10.1016/j.jbo.2022.100420

Ejemplares similares